Gain-of-function variants in SMAD4 compromise respiratory epithelial function
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2024.08.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Mark E Lindsay und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Genetics Program, Massachusetts General Hospital, Boston, Mass; Cardiovascular Research Center, Department of Medicine, Massachusetts …. Hauptthemen laut MEDLINE: Smad4 Protein, Gain of Function Mutation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: Myhre syndrome is an exceedingly rare yet increasingly diagnosed genetic disorder arising from germline variants in the SMAD4 gene. Its core manifestation is the progression of stiffness and fibrosis across multiple organs. Individuals with Myhre syndrome exhibit a propensity for upper respiratory tract remodeling and infections. The molecular and cellular mechanisms underlying this phenotype remain unclear. OBJECTIVE: We sought to investigate how SMAD4 pathogenic variants associated with Myhre syndrome affect SMAD4 protein levels, activation, and physiological functions in patient-derived nasal epithelial cells. METHODS: Clinical observations were conducted on a cohort of 47 patients recruited at Massachusetts General Hospital from 2016 to 2023. Nasal epithelial basal cells were isolated and cultured from inferior turbinate brushings of healthy subjects (n = 8) and patients with Myhre syndrome (n = 3; SMAD4-Ile500Val, Arg496Cys, and Ile500Thr). Transcriptomic analysis and functional assays were performed to assess SMAD4 levels, transcriptional activity, and epithelial cell host defense functions, including cell proliferation, mucociliary differentiation, and bacterial elimination. RESULTS: Clinical observations revealed a prevalent history of otitis media and sinusitis among most individuals with Myhre syndrome. Analyses of nasal epithelial cells indicated that SMAD4 mutations do not alter SMAD4 protein stability or upstream regulatory SMAD phosphorylation but enhance signaling transcriptional activity, supporting a gain-of-function mechanism, likely attributable to increased protein-protein interaction of the SMAD complex. Consequently, Myhre syndrome nasal basal cells exhibit reduced potential in cell proliferation and mucociliary differentiation. Furthermore, Myhre syndrome nasal epithelia are impaired in bacterial killing. CONCLUSIONS: Compromised innate immunity originating from epithelial cells in Myhre syndrome may contribute to increased susceptibility to upper respiratory tract infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Genetics Program, Massachusetts General Hospital, Boston, Mass; Cardiovascular Research Center, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
- Medical Genetics, Department of Pediatrics, Mass General for Children, Boston, Mass.
- Cardiovascular Research Center, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
- Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, Mass.
- Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pa.
- Department of Radiology, Massachusetts General Hospital, Boston, Mass.
Förderung
- NCATS NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Lindsay, M. E., Scimone, E. R., Lawton, J., Richa, R., Yonker, L. M., Di, Y. P., Buch, K., Ouyang, W., Mo, X., Lin, A. E., & Mou, H. (2025). Gain-of-function variants in SMAD4 compromise respiratory epithelial function. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.08.024
Vancouver
Lindsay ME, Scimone ER, Lawton J, Richa R, Yonker LM, Di YP, et al. Gain-of-function variants in SMAD4 compromise respiratory epithelial function. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2024.08.024
BibTeX
@article{Lindsay2025,
author = {Lindsay, Mark E and Scimone, Eleanor R and Lawton, Joseph and Richa, Rashmi and Yonker, Lael M and Di, Yuanpu P and Buch, Karen and Ouyang, Wukun and Mo, Xiulei and Lin, Angela E and Mou, Hongmei},
title = {Gain-of-function variants in SMAD4 compromise respiratory epithelial function},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2024.08.024}
}
EUVIMED